Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: old 'n cranky who wrote (12645)	2/8/2020 9:46:40 AM
From: Savant	Respond to of 12871

Clever, aren't they....the new number might be quick, but it sure is dirty.... The number of shares before the preferred, is>> 3,853,675 and of those, insiders' shares, subject to reporting, if bought or sold... is considerable...and I've seen no filings in re: buying or selling from insiders...so.... Makes the trading volume highly suspicious, IMO The suspicious volume started on Jan 21...4.42 Mln vol....and rolled into many X factors of actual float...magic

To: old 'n cranky who wrote (12645)	2/8/2020 9:39:27 PM
From: old 'n cranky	Respond to of 12871

It will take some time to develop a reconciliation of the old 255,714 shares to the new 398,278...it looks a little fishy to me Here's why. Based on the tables called... BENEFICIAL OWNERSHIP OF COMPANY COMMON STOCK BY DIRECTORS, OFFICERS AND PRINCIPAL STOCKHOLDERS from 10/14/19 to 1/13/20: TheraCour was issued 100,000 Preferred A shares A Diwan was issued 10,000 M Vyas was issued 774 Who got the other 31,790 A shares? (142,564 - 110,774)